• Vaxart granted director Raquel C. Bono 78,800 common shares on Oct. 16, 2026.
• She also received stock options to buy 157,400 common shares at an exercise price of $0.4527.
• The options expire on Oct. 16, 2036.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxart Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-033037), on October 20, 2026, and is solely responsible for the information contained therein.